UroGen Pharma Ltd. — Investor Relations & Filings
Filings indexed
539
across all filing types
Latest filing
2026-05-06
Interim / Quarterly Rep…
Country
IL
Israel
Listing
US
URGN
UroGen Pharma Ltd. is a biopharmaceutical company focused on developing and commercializing treatments for urothelial and specialty cancers. The company aims to transform the treatment paradigm in uro-oncology by providing novel therapeutic options. Its approach is centered on the proprietary RTGel™ reverse-thermal hydrogel technology, which enables sustained local delivery of therapies. The company's commercial product, ZUSDURI™, is a treatment for recurrent Low-Grade, Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC). UroGen's clinical pipeline includes investigational candidates such as UGN-103, also being developed for LG-IR-NMIBC, as part of its commitment to advancing therapies for urologic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | |
| 8-K - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | |
| DEF 14A - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-04-30 | English | |
| 10-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | |
| 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | |
| 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 41828679 | 10-Q - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | ||
| 41825233 | 8-K - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-05-06 | English | ||
| 39218358 | DEF 14A - UroGen Pharma Ltd. (0001668243) (Filer) | 2026-04-30 | English | ||
| 32896251 | 10-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | ||
| 32896250 | 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | ||
| 32896249 | 8-K - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-03-02 | English | ||
| 32896247 | 4 - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-02-27 | English | ||
| 32896248 | 4 - UROGEN PHARMA LTD. (0001668243) (Filer) | 2026-02-19 | English | ||
| 31213109 | 4 Filing | 2026-02-11 | English | ||
| 31213111 | 4 Filing | 2026-02-04 | English | ||
| 31213113 | 4 Filing | 2026-02-03 | English | ||
| 31213110 | 4 Filing | 2026-02-03 | English | ||
|
2025
3 filings
| |||||
| 12942222 | FORM 4 | 2025-12-01 | English | ||
| 12942226 | FORM 4 | 2025-12-01 | English | ||
| 12942227 | FORM 4 | 2025-12-01 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
UroGen Pharma Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32312/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32312 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32312 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32312 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32312}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for UroGen Pharma Ltd. (id: 32312)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.